Search

This report traces the progressive expansion of health accounts (HA) to measure national health expenditures, from the first attempts in 1926 by the American Medical Association to the present day. Milestones in the development of A System of Health Accounts (SHA) are covered, from the economic background to initial efforts by a few countries and organizations, to the need for a set of accounting standards for health care systems, and finally, to consolidation with SHA 2011. International organizations, such as the World Health Organization, Organization for Economic Cooperation and Development, Eurostat, the World Bank, and the United States Agency for International Development have been critical to expanding national HA exercises and ensuring that these are standardized, comparable, and become institutionalized. National efforts to track health expenditures have not only enriched collective results, but have become an important component of global leadership, informing policy the world over. More than 100 countries have created HA under the global standard and have gained a better understanding of health spending and financial flows. These results are key for monitoring progress toward national and global initiatives, such as the Sustainable Development Goals and Universal Health Coverage. Challenges remain to be tackled, among them institutionalization and quality of results. Social responsibility for improving data sources and expanding the generation and usability of health accounts are also needed. [ABSTRACT FROM AUTHOR]

Objective. To characterize the design of excise taxes on sugar-sweetened beverages (SSBs) in Latin America and the Caribbean and assess opportunities to increase their impact on SSB consumption and health. Methods. A comprehensive search and review of the legislation in effect as of March 2019, collected through existing Pan American Health Organization and World Health Organization monitoring tools, secondary sources, and surveying ministries of finance. The analysis focused on the type of products taxed, and the structure and base of these excise taxes. Results. Out of the 33 countries analyzed, 21 apply excise taxes on SSBs. Seven countries also apply excise taxes on bottled water and at least four include sugar-sweetened milk drinks. Ten of these excise taxes are ad valorem with some tax bases set early in the value chain, seven are amount-specific, and four have either a combined or mixed structure. Three countries apply excise taxes based on sugar concentration. Conclusions. While the number of countries applying excise taxes on SSBs is promising, there is great heterogeneity in design in terms of structure, tax base, and products taxed. Existing excise taxes could be further leveraged to improve their impact on SSB consumption and health by including all categories of SSBs, excluding bottled water, and relying more on amount-specific taxes regularly adjusted for inflation and possibly based on sugar concentration. All countries would benefit from additional guidance. Future research should aim to address this gap. [ABSTRACT FROM AUTHOR]

Objective. To estimate the budgetary impact of excess cesarean deliveries without clinical indication compared to vaginal deliveries in the Unified Health System (SUS) in Brazil. Methods. The analysis was based on a static model. The reference population was that of pregnant women at normal risk. The time horizon was 5 years. A Poisson regression model was used to estimate the number of live births from 2016 to 2020. Calculation of the direct cost of elective cesarean delivery and vaginal delivery was based on two previous studies, in which the expected monetary value of the procedures was calculated through an analytical decision model that included all clinical events from admission until discharge. The reference scenario for this analysis considered 29% of excess cesareans in the country. Results. The total cost of delivery and birth care for primiparous and multiparous women without uterine scar in the reference scenario was US$ 707 500 000 for the year 2016. In scenario 1 (best scenario), which considered only vaginal delivery for these pregnant women, there was a cost reduction of US$ 76 500 000 per year. For multiparous women, comparison of the reference scenario with the best scenario showed savings of more than US$ 4 000 000 per year. Conclusions. The results indicate that the incentive to vaginal delivery generates savings. [ABSTRACT FROM AUTHOR]

Objective. The objective of this study was to look at trends in the affordability of beer and soft drinks in 15 Latin American countries. Methods. The data correspond to government statistics pertaining to price indices for beer and soft drinks, the consumer price index, and the nominal wage index based on monthly frequency. The methods involved the performance of an econometric analysis, using time series, to measure the expected rate of increase in the absolute affordability indicator (using nominal prices) or the relative affordability indicator (using general prices) for soft drinks and beers. Results. In nine of the 15 countries analyzed, the affordability of soft drinks or beer (whether absolute or relative) has shown a statistically significant increase. In the case of soft drinks, absolute affordability increased in five countries (Chile, Colombia, Costa Rica, Ecuador, and Uruguay) and decreased in Mexico. In the case of beer, it increased in Colombia and Ecuador, remained unchanged in Argentina, Brazil, Chile, Costa Rica, and Uruguay, and dropped in Mexico. Conclusions. Although most countries levy taxes on beer and soft drinks, the effect of such taxes on price has not been enough to reduce the affordability of these products in all countries in the sample. Taxes should be modified to make these beverages less affordable and have an impact on their consumption. [ABSTRACT FROM AUTHOR]

Objective. To evaluate the Programa Mais Médicos (More Doctors Program; PMM) in Brazil by estimating the proportional increase in the number of doctors in participating municipalities and the program costs, stratified by cost component and funding source. Methods. Official data from the 2013 edition of Demografia Médica no Brasil (Medical Demography in Brazil) was used to estimate the number of doctors prior to PMM. The number of doctors at the end of the fourth PMM recruiting cycle (July 2014) was obtained from the Ministry of Health. Cost components were identified and estimated based on PMM legislation and guidelines. The participating municipalities were chosen based on four criteria, all related to vulnerability. Results. The PMM provided an additional 14 462 physicians to highly vulnerable, remote areas in 3 785 municipalities (68% of the total) and 34 Special Indigenous Sanitary Districts. There was a greater increase of physicians in the poorest regions (North and Northeast). The estimated annual cost of US$ 1.1 billion covered medical provision, continuing education, and supervision/mentoring. Funding was largely centralized at the federal level (92.6%). Conclusion. The cost of PMM is considered relatively moderate in comparison to its potential benefits for population health. The greater increase of doctors for the poorest and most vulnerable met the target of correcting imbalances in health worker distribution. The PMM experience in Brazil can contribute to the debate on reducing physician shortages. [ABSTRACT FROM AUTHOR]

Obesity is a compelling example of the challenges of championing and mobilizing a response that involves the whole of government and all of society. This paper discusses the need for economic rationales to strengthen the case for government intervention on obesity, with a view to better engaging the expertise and resources of nonhealth sectors. The paper also briefly reviews economic theory and evidence that could support an integrated multisectoral rationale for action, noting opportunities to expand the integration of economic evidence in the Americas. [ABSTRACT FROM AUTHOR]

This report traces the progressive expansion of health accounts (HA) to measure national health expenditures, from the first attempts in 1926 by the American Medical Association to the present day. Milestones in the development of A System of Health Accounts (SHA) are covered, from the economic background to initial efforts by a few countries and organizations, to the need for a set of accounting standards for health care systems, and finally, to consolidation with SHA 2011. International organizations, such as the World Health Organization, Organization for Economic Cooperation and Development, Eurostat, the World Bank, and the United States Agency for International Development have been critical to expanding national HA exercises and ensuring that these are standardized, comparable, and become institutionalized. National efforts to track health expenditures have not only enriched collective results, but have become an important component of global leadership, informing policy the world over. More than 100 countries have created HA under the global standard and have gained a better understanding of health spending and financial flows. These results are key for monitoring progress toward national and global initiatives, such as the Sustainable Development Goals and Universal Health Coverage. Challenges remain to be tackled, among them institutionalization and quality of results. Social responsibility for improving data sources and expanding the generation and usability of health accounts are also needed. [ABSTRACT FROM AUTHOR]

This paper opens a discussion on the main features of an investment case for obesity prevention and control, by scanning available evidence on existing approaches and by highlighting contextual considerations and evidence for Latin America and the Caribbean. We call on researchers and analysts in the field to update and broaden existing methods of economic analyses to better reflect the multisectoral nature of an investment case for obesity prevention and control. We also identify research gaps and further work required to advance methods and evidence towards investment cases throughout the Americas. [ABSTRACT FROM AUTHOR]

This paper presents, in the context of the universal health strategy, some general considerations and economic actions on financing, efficiency and other economic challenges of public health in Cuba. Official bibliographic sources of the Cuban state were revised up to 2015. The analyses of time series were adjusted to constant prices of 1997 and the official exchange rate of 1 Cuban peso = 1 US dollar. The Cuban National Health System has a solid infrastructure, consisting of a wide network of health facilities that guarantee full coverage, access and equity in the services provided to the population through qualified human resources. An economic analysis was carried out under the conceptual framework of the universal health strategy, with an emphasis in financing, efficiency and challenges of the Cuban public health system to maintain the right to health of its citizens, equity, coverage and access to the services provided, including the elimination of economic, sociocultural and gender barriers, as well as solidarity with the Cuban population and the world. It was concluded that in Cuba, universal health is considered one of its most valuable achievements, although it is needed a most efficient analysis of reliable and available sources, research and application of results to practice on the strengths and weaknesses of the system regarding health economics, updating and a better use of resources and technologies, as well as deepening the lessons learned and facing remaining challenges. [ABSTRACT FROM AUTHOR]

Objective. Identify the most relevant, applicable, and priority good practice principles in health technology assessment (HTA) in Latin America, and potential barriers to implementing them in the region. Methods. HTA good practice principles postulated worldwide were identified and then explored through a deliberative process in a forum of evaluators, funders, and technology producers. Results. Forty-two representatives from ten Latin American countries participated in the forum. The good practice principles postulated at the international level were considered valid and potentially applicable in Latin America. Five principles were identified as priorities and as having greater potential to be expanded at this time: transparency in carrying out HTA; involvement of stakeholders in the HTA process; existence of mechanisms to appeal decisions; existence of clear mechanisms for HTA priority-setting; and existence of a clear link between assessment and decision-making. The main challenge identified was to find a balance between application of these principles and available resources, to prevent the planned improvements from jeopardizing report production times and failing to meet decision-makers' needs. Conclusions. The main recommendation was to gradually advance in improving HTA and its link to decision-making by developing appropriate processes for each country, without attempting to impose, in the short term, standards taken from examples at the international level without adequate adaptation to the local context. [ABSTRACT FROM AUTHOR]

Objective. Health technology assessment (HTA) has been adopted by countries in order to improve allocative efficiency in their health systems. This study aimed to describe and analyze the HTA decision-making process in the Region of the Americas. Methods. A literature review was done to better understand the HTA situation in the Region. Also, in 2014 and 2015, individuals responsible for conducting HTA in countries of the Americas were identified and received a questionnaire on HTA and the decision-making process. Results. A total of 46 questionnaire responses were obtained, from 30 countries. The respondents were similar in terms of their institutions, main funding sources, and technology types assessed. Of the 46 respondents, 23 (50%) work for their respective ministry of health. Also, 36 (78%) undertake and/or coordinate HTA through coverage and reimbursement/pricing decisions and other HTA-related activities, while 24 (52%) use HTA for emerging technologies. While some countries in the Region have created formal HTA units, there is a weak link between the HTA process and decision-making. Most of the countries with recognized HTA institutions are members of the Health Technology Assessment Network of the Americas (RedETSA). Despite the advances in the Region overall, most countries in Central America and the Caribbean are still at the early stages of implementing HTA to support decision-making. Conclusions. Many countries in the Americas have benefited from the exchange and capacity-building opportunities within RedETSA. However, there are still many challenges to overcome in the Region in terms of the discussion and creation of HTA-related policies. [ABSTRACT FROM AUTHOR]

Objective. To propose a tool for critical analysis of economic evaluation studies based on a synthesis of checklists and guidelines available in the literature. Methods. The following databases were searched: MEDLINE, Embase, Centre for Reviews and Dissemination, and International Society for Pharmacoeconomics and Outcomes Research. Two investigators independently selected the studies and extracted the data of interest. The number of questions that the checklists contained were counted on the following domains: study design, measurement of costs and health outcomes, analysis and interpretation of results, and general information. A matrix containing the items in each domain was constructed, and a tool for critical analysis was built based on that matrix.Results. The literature search retrieved 406 non-duplicated articles, 19 of which were included in the study. Five hundred sixty-six questions were identified in the checklists employed in these studies: 109 (19%) dealt with health outcomes, 93 (16%)with quantification of costs, 73 (13%) with modeling, 54 (10%) with generalization of findings, and 52 (9%) with uncertainty. The resulting critical analysis checklist contains32 questions organized into four domains: study design, measurement of costs and health outcomes, analysis and interpretation of results, and general information.Conclusions. The proposed critical analysis checklist is useful to standardize the assessment of the quality of evidence in all types of economic evaluations. [ABSTRACT FROM AUTHOR]